journal article·2024-08-28Open access

Charged Gold Nanoparticles for Target Identification–Alignment and Automatic Segmentation of CT Image-Guided Adaptive Radiotherapy in Small Hepatocellular Carcinoma

Jianjun Lai, Zhizeng Luo, Jiping Liu, Haili Hu, Hao Jiang, Pengyuan Liu, Li He, Weiyi Cheng, Weiye Ren, Yajun Wu, Ji-Gang Piao, Zhibing Wu

Nano Letters· Volume 24· Issue 34

Abstract

High Resolution Image Download MS PowerPoint Slide Because of the challenges posed by anatomical uncertainties and the low resolution of plain computed tomography (CT) scans, implementing adaptive radiotherapy (ART) for small hepatocellular carcinoma (sHCC) using artificial intelligence (AI) faces obstacles in tumor identification–alignment and automatic segmentation. The current study aims to improve sHCC imaging for ART using a gold nanoparticle (Au NP)-based CT contrast agent to enhance AI-driven automated image processing. The synthesized charged Au NPs demonstrated notable in vitro aggregation, low cytotoxicity, and minimal organ toxicity. Over time, an in situ sHCC mouse model was established for in vivo CT imaging at multiple time points. The enhanced CT images processed using 3D U-Net and 3D Trans U-Net AI models demonstrated high geometric and dosimetric accuracy. Therefore, charged Au NPs enable accurate and automatic sHCC segmentation in CT images using classical AI models, potentially addressing the technical challenges related to tumor identification, alignment, and automatic segmentation in CT-guided online ART.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Radiation Therapy and Dosimetry · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiation Oncology, Zhejiang Hospital, Hangzhou 310013, China

Instiute of Intelligent Control and Robotics, Hangzhou Dianzi University, Hangzhou 310018, China

Department of Radiation Physics, Zhejiang Cancer Hospital, Hangzhou 310022, China

School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China

Department of Pharmacy, Zhejiang Hospital, Hangzhou 310013, China

Department of Radiation Oncology, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou 310013, China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province

References (56)

Show source-provided references
1. 10.1016/j.ijrobp.2023.08.01510.1016/j.ijrobp.2023.08.015 ↗
2. 10.1016/j.jhepr.2022.10049810.1016/j.jhepr.2022.100498 ↗
3. 10.1016/j.canrad.2006.07.00410.1016/j.canrad.2006.07.004 ↗
4. 10.1016/j.tipsro.2019.10.00610.1016/j.tipsro.2019.10.006 ↗
5. 10.1016/j.tipsro.2020.08.00210.1016/j.tipsro.2020.08.002 ↗
6. 10.1038/s41467-022-34257-x10.1038/s41467-022-34257-x ↗
7. 10.1007/s11684-020-0761-110.1007/s11684-020-0761-1 ↗
8. 10.1016/j.ijrobp.2020.07.85610.1016/j.ijrobp.2020.07.856 ↗
9. 10.1109/TMI.2019.294832010.1109/TMI.2019.2948320 ↗
10. 10.1109/JBHI.2022.318197410.1109/JBHI.2022.3181974 ↗
11. 10.1007/s00330-021-07803-210.1007/s00330-021-07803-2 ↗
12. 10.1118/1.476775310.1118/1.4767753 ↗
13. 10.1200/JCO.2020.38.15_suppl.555310.1200/JCO.2020.38.15_suppl.5553 ↗
14. 10.1259/bjr/4132149210.1259/bjr/41321492 ↗
15. 10.1186/s13014-023-02356-810.1186/s13014-023-02356-8 ↗
16. 10.1016/j.clinimag.2022.04.01610.1016/j.clinimag.2022.04.016 ↗
17. 10.3390/ma1509335510.3390/ma15093355 ↗
18. 10.1021/ja071471p10.1021/ja071471p ↗
19. 10.1021/ja078176p10.1021/ja078176p ↗
20. 10.1021/acs.biomac.2c0140310.1021/acs.biomac.2c01403 ↗
21. 10.1038/s41551-022-00975-210.1038/s41551-022-00975-2 ↗
22. 10.1002/adbi.20200019310.1002/adbi.202000193 ↗
23. 10.1021/acsami.0c2262410.1021/acsami.0c22624 ↗
24. 10.1038/nnano.2016.7210.1038/nnano.2016.72 ↗
25. 10.1039/C8NA00190A10.1039/C8NA00190A ↗
26. 10.1080/02656736.2024.233520110.1080/02656736.2024.2335201 ↗
27. 10.3390/nano1109218110.3390/nano11092181 ↗
28. 10.7150/thno.6475910.7150/thno.64759 ↗
29. 10.1002/adma.20130008110.1002/adma.201300081 ↗
30. 10.1002/cmmi.170410.1002/cmmi.1704 ↗
31. 10.1002/anie.20221744810.1002/anie.202217448 ↗
32. 10.1002/adma.20230926110.1002/adma.202309261 ↗
33. 10.1016/j.ntm.2024.10003210.1016/j.ntm.2024.100032 ↗
34. 10.1016/j.ntm.2023.10000310.1016/j.ntm.2023.100003 ↗
35. 10.1039/C8NA00190A10.1039/C8NA00190A ↗
36. 10.1186/1752-1947-3-14010.1186/1752-1947-3-140 ↗
37. 10.1118/1.354436910.1118/1.3544369 ↗
38. 10.1016/j.jenvman.2022.11486910.1016/j.jenvman.2022.114869 ↗
39. 10.1007/s11548-022-02653-910.1007/s11548-022-02653-9 ↗
40. 10.1109/TMI.2019.294832010.1109/TMI.2019.2948320 ↗
41. 10.1016/j.compbiomed.2023.10683810.1016/j.compbiomed.2023.106838 ↗
42. 10.1088/1361-6560/abfce210.1088/1361-6560/abfce2 ↗
43. 10.3390/diagnostics1315250410.3390/diagnostics13152504 ↗
44. 10.1097/AS9.000000000000015510.1097/AS9.0000000000000155 ↗
45. 10.1016/j.compbiomed.2021.10468810.1016/j.compbiomed.2021.104688 ↗
46. 10.1109/TCBB.2022.319842510.1109/TCBB.2022.3198425 ↗
47. 10.7150/thno.2910110.7150/thno.29101 ↗
48. 10.1016/j.mtbio.2022.10022010.1016/j.mtbio.2022.100220 ↗
49. 10.1016/j.talanta.2021.12224510.1016/j.talanta.2021.122245 ↗
50. 10.1016/j.acra.2022.03.02710.1016/j.acra.2022.03.027 ↗
51. 10.1002/smtd.20200041610.1002/smtd.202000416 ↗
52. 10.1038/s41467-020-18311-010.1038/s41467-020-18311-0 ↗
53. 10.1186/s40824-023-00455-x10.1186/s40824-023-00455-x ↗
54. 10.1186/s12951-020-00617-210.1186/s12951-020-00617-2 ↗
55. Ronneberger, O.; Fischer, P.; Brox, T. U-Net: Convolutional Networks for Biomedical Image Segmentation. In Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015; Navab, N., Hornegger, J., Wells, W., Frangi, A., Eds. Lecture Notes in Computer Science, Vol. 9351; Springer: Cham, Switzerland, 2015; pp 234–241.10.1007/978-3-319-24574-4_28 ↗
56. Chen, J.; Lu, Y.; Yu, Q., et al. TransUNet: Transformers Make Strong Encoders for Medical Image Segmentation. arXiv, February 8, 2021, 2102.04306, ver. 1.10.48550/arXiv.2102.04306.10.48550/arXiv.2102.04306 ↗